Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Appointed CFO
Quarterly results
CC transcript

PALISADE BIO, INC. (CUR) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 4 Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Paid exercise price by delivering 397 shares @ $0.5501, valued at $218.4
Exercised 1,309 options to buy @ $0
09/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/14/2023 4 Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Paid exercise price by delivering 1,040 shares @ $0.7, valued at $728
Exercised 3,475 options to buy @ $0
07/06/2023 4 Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Paid exercise price by delivering 389 shares @ $1.764, valued at $686.2
Exercised 1,309 options to buy @ $0
04/05/2023 4 McRae Robert Curtis (COO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Paid exercise price by delivering 270 shares @ $2, valued at $540
Exercised 655 options to buy @ $0
04/05/2023 4 Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Paid exercise price by delivering 435 shares @ $2.01, valued at $874.4
Exercised 1,309 options to buy @ $0
02/08/2023 4 Finley John David (CEO, CFO, Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 41,700 options to buy @ $0
Granted 32,500 options to buy @ $0
Granted 57,200 options to buy @ $2.4, valued at $137.3k
01/06/2023 4 Finley John David (CEO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 5,236 options to buy @ $0
09/02/2022 4 Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Bought 19,481 shares @ $0.1437, valued at $2.8k
08/25/2022 4 Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Bought 7,350 shares @ $0.16, valued at $1.2k
08/18/2022 4 Hallam Thomas (CEO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Bought 40,000 shares @ $0.25, valued at $10k
Bought 40,000 options to buy @ $0.25, valued at $10k
08/18/2022 4 Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Bought 100,000 shares @ $0.25, valued at $25k
Bought 100,000 options to buy @ $0.25, valued at $25k
05/02/2022 4 Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Acquired 12,545 shares @ $0
03/31/2022 4 Dawson Michael John (Chief Medical Officer) has filed a Form 4 on PALISADE BIO, INC.
Txns: Bought 15,000 shares @ $1.1395, valued at $17.1k
03/29/2022 4 Hallam Thomas (CEO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Bought 10,000 shares @ $1.18, valued at $11.8k
03/25/2022 4 Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Bought 7,500 shares @ $1.0899, valued at $8.2k
02/22/2022 4 Hallam Thomas (CEO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 156,600 options to buy @ $0.95, valued at $148.8k
02/22/2022 4 Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 64,800 options to buy @ $0.95, valued at $61.6k
02/22/2022 4 Dawson Michael John (Chief Medical Officer) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 32,400 options to buy @ $0.95, valued at $30.8k
02/10/2022 4 Dawson Michael John (Chief Medical Officer) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 39,294 options to buy @ $2.32, valued at $91.2k
02/10/2022 4 Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 178,091 options to buy @ $2.32, valued at $413.2k
02/10/2022 4 Hallam Thomas (CEO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 267,868 options to buy @ $2.32, valued at $621.5k
02/10/2022 4 Trenschel Robert J. (Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 48,340 options to buy @ $2.32, valued at $112.1k
02/10/2022 4 Williams Donald Allen (Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 48,340 options to buy @ $2.32, valued at $112.1k
02/10/2022 4 Neal James R (Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 48,340 options to buy @ $2.32, valued at $112.1k
02/10/2022 4 Diaz Stephanie (Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 48,340 options to buy @ $2.32, valued at $112.1k
02/10/2022 4 Wei Binxian (Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 48,340 options to buy @ $2.32, valued at $112.1k
02/10/2022 4 Csimma Cristina (Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 48,340 options to buy @ $2.32, valued at $112.1k
02/10/2022 4 GRAY MARY ANN (Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Granted 48,340 options to buy @ $2.32, valued at $112.1k
09/22/2021 4 Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Bought 2,000 shares @ $2.44, valued at $4.9k
09/22/2021 4 Hallam Thomas (CEO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Bought 6,000 shares @ $2.49, valued at $14.9k
09/13/2021 4 Trenschel Robert J. (Director) has filed a Form 4 on PALISADE BIO, INC.
Txns: Bought 1,750 shares @ $2.75, valued at $4.8k
Bought 2,707 shares @ $2.78, valued at $7.5k
Bought 5,000 shares @ $2.75, valued at $13.8k
Bought 3,400 shares @ $2.89, valued at $9.8k
Bought 2,142 shares @ $2.98, valued at $6.4k
08/30/2021 4 Finley John David (CFO) has filed a Form 4 on PALISADE BIO, INC.
Txns: Bought 1,600 shares @ $2.63, valued at $4.2k
Bought 8,400 shares @ $2.65, valued at $22.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy